Skip to content
Nonprofiteer
← INTERNATIONAL SOCIETY FOR PHARMACEUTICAL ENGINEERING INC

Form 990 for tax year 2023

Filed by INTERNATIONAL SOCIETY FOR PHARMACEUTICAL ENGINEERING INC.

Totals

Total revenue
$18,333,665
Total expenses
$17,091,709
Contributions and grants received
$0
Grants paid
$0
Program service revenue
$17,465,293
Investment income
$266,247
Other revenue
$602,125
Total assets, end of year
$17,990,571
Total liabilities, end of year
$8,589,636
Net assets or fund balances, end of year
$9,400,935
Program services expenses (Part IX)
not reported
Management and general expenses
not reported
Fundraising expenses
not reported
Program service expenses (Part III)
not reported

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 2a · Program service revenue: PROFESSIONAL DEVELOPMENT

    total $9,931,474 · related or exempt $9,931,474

  • 2b · Program service revenue: PUBLICATIONS

    total $4,158,566 · related or exempt $3,546,226 · unrelated business $612,340

  • 2c · Program service revenue: MEMBERSHIP

    total $3,375,253 · related or exempt $3,375,253

  • 3 · Investment income

    total $241,863 · excluded $241,863

  • 7a · Gross sales of assets other than inventory

    securities $1,030,257

  • 7b · Less cost or other basis and sales expenses

    securities $1,005,873

  • 7c · Gain or loss

    securities $24,384

  • 7d · Net gain or loss

    total $24,384 · excluded $24,384

  • 11a · Other revenue: SUBLEASE REVENUE

    total $303,588 · excluded $303,588

  • 11b · Other revenue: NEWSLETTER ADVERTISING

    total $175,319 · unrelated business $175,319

  • 11c · Other revenue: ONLINE BANNER ADVERTISING

    total $53,996 · unrelated business $53,996

  • 11d · All other revenue

    total $69,222 · unrelated business $45,618 · excluded $23,604

  • 11e · Other revenue, total

    $602,125

Functional expenses

Part IX, the statement of functional expenses.

  • 5 · Compensation of officers, directors and key employees

    total $1,320,779

  • 7 · Other salaries and wages

    total $4,602,566

  • 8 · Pension plan contributions

    total $210,143

  • 9 · Other employee benefits

    total $474,147

  • 10 · Payroll taxes

    total $406,737

  • 11a · Fees: management

    total $208,037

  • 11b · Fees: legal

    total $82,602

  • 11c · Fees: accounting

    total $87,638

  • 11f · Fees: investment management

    total $40,061

  • 11g · Fees: other

    total $1,266,349

  • 12 · Advertising and promotion

    total $509,848

  • 13 · Office expenses

    total $704,018

  • 14 · Information technology

    total $677,193

  • 16 · Occupancy

    total $657,298

  • 17 · Travel

    total $458,550

  • 19 · Conferences, conventions and meetings

    total $1,907,525

  • 21 · Payments to affiliates

    total $575,234

  • 22 · Depreciation, depletion and amortization

    total $110,426

  • 23 · Insurance

    total $95,033

  • 24a · Other expenses: SITE COSTS

    total $1,285,752

  • 24b · Other expenses: FACULTY

    total $345,644

  • 24c · Other expenses: RETENTION

    total $308,366

  • 24d · Other expenses: CHAPTER EXPENSE

    total $265,796

  • 24e · All other expenses

    total $491,967

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $5,097,740 · end of year $4,757,376

  • 2 · Savings and temporary cash investments

    beginning of year $128,600 · end of year $154,476

  • 4 · Accounts receivable

    beginning of year $1,565,331 · end of year $1,604,748

  • 8 · Inventories for sale or use

    beginning of year $27,944 · end of year $25,538

  • 9 · Prepaid expenses and deferred charges

    beginning of year $440,363 · end of year $677,469

  • 10a · Land, buildings and equipment: cost or other basis

    $2,477,179

  • 10b · Land, buildings and equipment: accumulated depreciation

    $2,165,661

  • 10c · Land, buildings and equipment, net

    beginning of year $173,051 · end of year $311,518

  • 11 · Investments: publicly traded securities

    beginning of year $6,163,438 · end of year $7,994,526

  • 15 · Other assets

    beginning of year $2,662,950 · end of year $2,464,920

  • 17 · Accounts payable and accrued expenses

    beginning of year $2,665,561 · end of year $2,215,689

  • 19 · Deferred revenue

    beginning of year $3,427,772 · end of year $3,679,187

  • 25 · Other liabilities

    beginning of year $2,609,689 · end of year $2,694,760

  • 27 · Net assets without donor restrictions

    beginning of year $7,556,395 · end of year $9,400,935

Mission and programs · 2023

Mission

ISPE IS THE GLOBAL INDUSTRY LEADER IN CONNECTING PHARMACEUTICAL KNOWLEDGE TO DELIVER MANUFACTURING AND SUPPLY CHAIN INNOVATION, OPERATIONAL EXCELLENCE, AND REGULATORY INSIGHTS TO ENHANCE INDUSTRY EFFORTS TO DEVELOP, MANUFACTURE AND RELIABLY DELIVER QUALITY MEDICINES TO PATIENTS.

Activities or mission (Part I)

TO LEAD SCIENTIFIC, TECHNICAL AND REGULATORY ADVANCEMENT THROUGHOUT THE ENTIRE PHARMACEUTICAL LIFECYCLE.

  • PROFESSIONAL DEVELOPMENT CONSISTS PRIMARILY OF CONFERENCES AND TRAINING COURSES TO KEEP INDUSTRY PROFESSIONALS INFORMED OF THE LATEST TECHNOLOGICAL AND REGULATORY TRENDS AND TO HELP THE PHARMACEUTICAL MANUFACTURING PROFESSION AS A WHOLE TO ENSURE THE SAFETY OF THE WORLD'S SUPPLY OF MEDICINES.

  • MEMBERSHIP DUES INCLUDE COMMUNICATION OF BENEFITS TO MEMBERS, SUPPORT BY MEMBER SERVICES, AND MANAGEMENT AND OVERSIGHT OF THE ISPE CHAPTERS AND AFFILIATES. PROGRAMS INCLUDE WOMEN IN PHARMA, EMERGING LEADERS, AND FACILITY OF THE YEAR AWARDS.

  • PUBLICATIONS INCLUDE SUBSCRIPTIONS AND ARTICLE REPRINTS PROVIDING THE MOST UP-TO-DATE INFORMATION ON THE LATEST TECHNOLOGICAL AND REGULATORY TRENDS IN THE PHARMACEUTICAL MANUFACTURING INDUSTRY. MEMBERS RECEIVE A SUBSCRIPTION TO THE PHARMACEUTICAL ENGINEERING MAGAZINE, WHICH PROVIDES A COMPREHENSIVE SELECTION OF PRACTICAL APPLICATION ARTICLES AND INFORMATION OF IMPORTANCE TO THE INDUSTRY AND MEMBERSHIP. GUIDANCE DOCUMENTS INCLUDE THE DEVELOPMENT AND PUBLISHING OF GUIDANCE INFORMATION INCLUDING BEST PRACTICES AND INNOVATIVE AND EFFECTIVE SOLUTIONS TO INDUSTRY CHALLENGES.

  • PUBLICATIONS

As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Thomas Hartman

    PRESIDENT & CEO

    Total calculated
    $520,136
    From this org
    $496,958
    From related orgs
    $0
    Other
    $23,178
    Hours/week
    40 + 1 related

    Schedule J breakdown matched by us

    Base
    $420,458
    Bonus
    $76,500
    Other
    $0
    Deferred
    $22,577
    Nontaxable benefits
    $601
    Filer's total
    $520,136
  • Mark Hernick

    CHIEF FINANCIAL & OPERATING OFFICER

    Total calculated
    $317,931
    From this org
    $292,000
    From related orgs
    $0
    Other
    $25,931
    Hours/week
    40 + 1 related

    Schedule J breakdown matched by us

    Base
    $240,446
    Bonus
    $51,554
    Other
    $0
    Deferred
    $16,933
    Nontaxable benefits
    $8,998
    Filer's total
    $317,931
  • Bradley Ettinger

    VP, SALES & MARKETING

    Total calculated
    $293,867
    From this org
    $260,950
    From related orgs
    $0
    Other
    $32,917
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $220,135
    Bonus
    $40,815
    Other
    $0
    Deferred
    $15,772
    Nontaxable benefits
    $17,145
    Filer's total
    $293,867
  • Jessica Bleess

    VP, CONFERENCES & DIGITAL ENGAGEMENT

    Total calculated
    $188,845
    From this org
    $169,471
    From related orgs
    $0
    Other
    $19,374
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $151,453
    Bonus
    $18,018
    Other
    $0
    Deferred
    $11,128
    Nontaxable benefits
    $8,246
    Filer's total
    $188,845
  • Philip Lipnick

    DIRECTOR, INFORMATION TECHNOLOGY

    Total calculated
    $186,527
    From this org
    $159,271
    From related orgs
    $0
    Other
    $27,256
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $141,605
    Bonus
    $17,666
    Other
    $0
    Deferred
    $10,550
    Nontaxable benefits
    $16,706
    Filer's total
    $186,527
  • Timothy Postlethwaite

    DIRECTOR, TECHNICAL COMMUNITIES

    Total calculated
    $170,498
    From this org
    $137,254
    From related orgs
    $0
    Other
    $33,244
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $122,183
    Bonus
    $15,071
    Other
    $0
    Deferred
    $9,254
    Nontaxable benefits
    $23,990
    Filer's total
    $170,498
  • Tori Johnson

    DIRECTOR, DEVELOPMENT & FOUNDATION OPERATIONS

    Total calculated
    $169,360
    From this org
    $150,048
    From related orgs
    $0
    Other
    $19,312
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $142,738
    Bonus
    $7,310
    Other
    $0
    Deferred
    $10,314
    Nontaxable benefits
    $8,998
    Filer's total
    $169,360
  • Rochelle May

    SR. DIRECTOR, PUBLICATIONS

    Total calculated
    $165,639
    From this org
    $141,257
    From related orgs
    $0
    Other
    $24,382
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $126,846
    Bonus
    $14,411
    Other
    $0
    Deferred
    $9,467
    Nontaxable benefits
    $14,915
    Filer's total
    $165,639
  • Jessica Hardy

    AVP, MEMBERSHIP & CHAPTER RELATIONS

    Total calculated
    $164,689
    From this org
    $139,662
    From related orgs
    $0
    Other
    $25,027
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $125,272
    Bonus
    $14,390
    Other
    $0
    Deferred
    $9,453
    Nontaxable benefits
    $15,574
    Filer's total
    $164,689
  • Scott Billman

    CHAIR

    Total calculated
    $0
    Hours/week
    1 + 1 related
  • Jeff Biskup PE

    VICE CHAIR

    Total calculated
    $0
    Hours/week
    1 + 1 related
  • Ylva Ek

    SECRETARY

    Total calculated
    $0
    Hours/week
    1
  • Vivianne Arencibia

    TREASURER

    Total calculated
    $0
    Hours/week
    1
  • Mike Rutherford

    PAST CHAIR

    Total calculated
    $0
    Hours/week
    1
  • Jourg Zimmermann

    PAST CHAIR (OUTGOING 2023)

    Total calculated
    $0
    Hours/week
    1
  • Nina Cauchon PhD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • David Churchward

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Liz Dooley Msc

    DIRECTOR (INCOMING 2023)

    Total calculated
    $0
    Hours/week
    1
  • Norman Goldschmidt

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1 + 1 related
  • Michael Martin

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Sarah Miksinski

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Teresa Minero

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1 + 1 related
  • Georg Singewald PhD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Hirofumi Suzuki

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1 + 1 related
  • Tim Watson PhD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1 + 1 related

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Independent compensation consultant
  • 3 · Written employment contract
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

No itemized grants to organizations on this return.

Activities outside the United States

From Schedule F of this return, as filed.

Offices (line 3c)
1
Employees, agents and contractors (line 3c)
2
Expenditures and investments (line 3c)
$2,306,000

At most 25 lines of each part are listed here. Schedule F names no grantee, so each line is a region and its money.

Activities by region (Part I)

Region Offices Employees Activity Specific services Expenditures
EAST ASIA AND THE PACIFIC 1 1 PROGRAM SERVICES PROFESSIONAL DEVELOPMENT, CONFERENCES, AND MEMBER SERVICES $569,000
EUROPE 0 1 PROGRAM SERVICES PROFESSIONAL DEVELOPMENT, CONFERENCES, AND MEMBER SERVICES $1,737,000
Transferred property to a foreign corporation during the year (line 1)
No
Had an interest in a foreign trust (line 2)
No
Owned an interest in a foreign corporation (line 3)
No
Was a shareholder of a passive foreign investment company or qualified electing fund (line 4)
No
Owned an interest in a foreign partnership (line 5)
No
Had operations in or related to a boycotting country (line 6)
No

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

Taxable family on this return

Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.

Disregarded entities

Part I: entities that legally are the filer and file no return of their own.

  • SHANGHAI ISPE PHARMACEUTICAL INFORMATION CO LTD

    INDUSTRY ASSOCIATION · CH · income -$58,443 · assets $153,165

    Directly controlled by ISPE

  • INTERNATIONAL SOCIETY FOR PHARMACEUTICAL ENGINEERING HONG KONG LIMITED

    INDUSTRY ASSOCIATION · HK · income $0 · assets $0

    Directly controlled by ISPE

Provenance

Return type
form_990
Tax year
2023
Filed
3 February 2025
IRS schema version
2023v6.0
Source object
202530349349301563

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.